18 June 2021
Freshfields advises Shenzhen Mindray on €545m acquisition of Hytest Invest Oy
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Richard Perks Lead | Freshfields | Partner | Not stated | Not stated |
| Alan Wang | Freshfields | Partner | Not stated | Not stated |
| Alastair Mordaunt | Freshfields | Partner | Not stated | Not stated |
| Thijs Flokstra | Freshfields | Not stated | Not stated | Not stated |
| Anna Nersesian | Freshfields | Not stated | Not stated | Not stated |
| Igor Gerber | Freshfields | Not stated | Not stated | Not stated |
| Aimen Mir | Freshfields | Not stated | Not stated | Not stated |
| Frank Röhling | Freshfields | Not stated | Not stated | Not stated |
| Bruce McCulloch | Freshfields | Not stated | Not stated | Not stated |
| Ya Ma | Freshfields | Counsel | Not stated | Not stated |
| Alexander Viktorov | Freshfields | Counsel | antitrust | Not stated |
| Aude Guyon | Freshfields | Counsel | antitrust | Not stated |
| Olga Chislova | Freshfields | Counsel | Employment law | Not stated |
Stated terms
- Stated value
- EUR 545m (€545m)
- What the figure measures
- Total transaction value
- Client
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Buy-side
- Counterparties
- Hytest Invest Oy (Target)